Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of PM060184 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor
- Status
- TERMINATED
- Phase
- PHASE1
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of EZN-2208 Pediatric Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of DS-2248 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study Of PF-04449913 Administered Alone In Select Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Nesvacumab (REGN910/ SAR307746)
- Status
- COMPLETED
- Phase
- PHASE1
Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
L19TNFα in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1